Skip To Main Content
Solange Peters on Muck Rack

Solange Peters

As seen in: Nature, Wiley, Wiley Online Library, The BMJ, Cell Press, The Lancet, Healio, HemOnc Today, Tribune de Genève, 24 heures and
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Solange

Contact Solange, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Nivolumab plus chemoradiotherapy followed by nivolumab with or without ipilimumab for untreated locally advanced stage III NSCLC: a randomized phase 3 trial

|
By Solange Peters, Daniel Tan, David E. Gerber, James Urbanic, Suresh S. Ramalingam, Jinming Yu, Ligang Xing, Achim Rittmeyer, Tudor-Eliade Ciuleanu, Juliana Cazares de Menezes, Hye Ryun Kim, Carlos Rojas, Konstantinos Syrigos, Hidetoshi Hayashi, Diego L Cortinovis, Debora S. Bruno, Antonio Calles, Luoying Yang, Dirk De Ruysscher, Anoop Haridass, Martin Kimmich, Raheel Nathani, Geetha Pudussery
| Nature Verified
Abstract Over 50% of persons with unresectable stage III non-small cell lung cancer (NSCLC) treated with standard-of-care concurrent chemoradiotherapy (CCRT) and durvalumab consolidation progress or die within 18 months. Here adults with untreated, unresectable stage III NSCLC were randomized to nivolumab plus CCRT followed by consolidation with nivolumab plus ipilimumab (arm A) or nivolumab alone (arm B) or CCRT followed by consolidation with durvalumab (arm C).
Open in Who Shared Issue with article?

Resolving sensitivity, specificity and signal contamination in Xenium spatial transcriptomics

|
By Mariia Bilous, Daria Buszta, Jonathan Bac, Senbai Kang, Yixing Dong, Stephanie Tissot, Solange Peters, Krisztian Homicsko, Raphael Gottardo, Sylvie Andre, Marina Alexandre Gaveta, Christel Voize
| Nature Verified
Abstract Spatial transcriptomics enables high-resolution gene expression mapping in intact tissues. Xenium is widely adopted for its reliability, accessibility and data quality, yet the properties and limitations of Xenium-derived data remain poorly characterized. Here we present one of the most comprehensive Xenium datasets so far, encompassing over 40 breast and lung tumor sections profiled using diverse gene panels.
Open in Who Shared Issue with article?

Correction: Diagnostic whole transcriptome sequencing in a series of 1233 FFPE solid tumor samples - British Journal of Cancer

|
By Markus Ball, Susanne Beck, Tina Fuchs Verified, Katja Lorenz, Alejandro Robles, Michael Allgäuer, Anna-Lena Volckmar, Iordanis Ourailidis, Regine Brandt, Petros Christopoulos, Michael Thomas, Annette Fink, Olaf Neumann, Michael Menzel, Martina Kirchner, Thoas Fioretos, Peter Schirmacher, Solange Peters, Jan Budczies, Albrecht Stenzinger, Daniel Kazdal, Darius Wlochowitz, Christiane Zgorzelski, Hannah Goldschmid, Huriye Seker-Cin, Fabian Schnecko
| Nature Verified
Correction to: British Journal of Cancer https://doi.org/10.1038/s41416-025-03307-8, published online 14 January 2026 In this article, the author’s name, Olaf Neumann, was incorrectly written as Olaf Neuman. The original article has been corrected.
Open in Who Shared View Duplicates (4) Issue with article?
See all 60 licensed articles (130 Total)